Cytomegalovirus gH Late Neutralizing Antigen antibody | HCMV16 (51C1)
Mouse anti Cytomegalovirus gH Late Neutralizing Antigen antibody, clone HCMV16 (51C1) recognizes Cytomegalovirus glycoprotein H (gH) late neutralizing antigen and reacts with MRC-5 infected cells. Mouse anti Cytomegalovirus gH Late Neutralizing Antigen antibody, clone HCMV16 (51C1) does not react with HSV, VZV, EBV or uninfected cells.
- Target Species
- Product Form
- Purified IgG - liquid
- Purified IgG prepared by affinity chromatography on Protein A
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
0.09% Sodium Azide (NaN3)
- Carrier Free
- Cytomegalovirus extracts.
- Approx. Protein Concentrations
- 1.0 mg/ml
- Store at +4oC or at -20oC if preferred.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
- Shelf Life
- 18 months from date of despatch.
- For research purposes only
Applications of Cytomegalovirus gH Late Neutralizing Antigen antibody
|Application Name||Verified||Min Dilution||Max Dilution|
|Immunohistology - Frozen|
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using the appropriate negative/positive controls.
Copyright © 2018 Bio-Rad Antibodies (formerly AbD Serotec)
Secondary Antibodies Available
Product Specific References
References for Cytomegalovirus gH Late Neutralizing Antigen antibody
Cranage, M.P. et al. (1988) Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H.
J Virol. 62 (4): 1416-22.
Hamilton, A.A. et al. (1997) A humanized antibody against human cytomegalovirus (CMV) gpUL75 (gH) for prophylaxis or treatment of CMV infections.
J Infect Dis. 176 (1): 59-68.
Milne, R.S. et al. (1998) Human cytomegalovirus glycoprotein H/glycoprotein L complex modulates fusion-from-without.
J Gen Virol. 79 ( Pt 4): 855-65.